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Abstract
Objectives—To examine changes between 2006 and 2011 in the proportion of HIV-positive 
patients newly-enrolled in HIV care with advanced disease and the median CD4+ cell count at 
enrollment; and identify patient-, facility-, and contextual-level factors associated with late 
enrollment in care in 2011.
Design—Cross sectional over time.
Methods—For time trends analyses, routinely-collected patient-level data (307,110 adults newly-
enrolled in 138 HIV clinical care facilities) in Kenya, Mozambique, Rwanda and Tanzania; and 
for analyses of correlates, patient-level data (46,201 in 195 facilities), and facility- and population-
level survey data were used. Late enrollment was defined as CD4+ count ≤350 cells/μl and/or 
WHO clinical stage 3/4.
Results—Late enrollment declined from 69.9% to 57.2%, (p<0.0001); median CD4+ count 
increased from 242 to 292 cells/μL (ptrend<0.0001). In 2011, risk of late enrollment was 
significantly higher for men and non-pregnant women vs. pregnant women; patients aged >25 vs. 
15-25 years; non-married vs. married; and those entering from sites other than prevention of 
mother to child transmission (PMTCT). More extensive HIV testing coverage in the region of a 
facility was significantly associated with lower risk of late enrollment.
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Conclusions—Despite improvement, in 2011, 57% of patients entered HIV care already ART-
eligible. The lower risk of late enrollment among those referred from PMTCT and in regions 
where HIV testing coverage was higher suggests that innovative approaches to rapidly increase 
testing uptake among people living with HIV prior to the development of symptoms have the 
potential to reduce late enrollment in care.
Introduction
Enrollment in HIV clinical care at advanced stage of disease (late enrollment in care) 
denotes critical missed opportunities to improve the health and well-being of HIV-positive 
people[1-3], and limits the potential of treatment at earlier stages of HIV disease to reduce 
HIV transmission[4] and potentially attenuate incidence[5-7]. Most studies of the 
prevalence, correlates, and outcomes of late enrollment in HIV care have been conducted in 
Europe and North America[1, 2, 8-18]. In sub-Saharan Africa, studies have largely focused 
on advanced disease at ART initiation[19, 20, 21]. Far less is known about advanced disease 
at enrollment in HIV care, a critical precursor to late ART initiation in this region[22]. In 
particular, whether the prevalence of late enrollment has changed over time with scale-up of 
care and treatment in sub-Saharan Africa is unknown. Additionally, multiple barriers to 
early diagnosis and prompt linkage to care likely exist in sub-Saharan Africa, but with few 
exceptions[23-25] only individual-level correlates have been examined. Characteristics of 
the HIV care facility and features of the broader social environment in which a facility 
operates[21, 26] may also influence timing of enrollment in HIV care.
Advanced HIV disease has frequently been defined as a CD4+ count ≤200 cells/μL, or even 
lower (e.g., [15, 17, 25]. In 2010, the World Health Organization (WHO) released expanded 
criteria for ART eligibility in low and middle income countries, recommending ART 
initiation for persons with CD4+ count <350 cells/μL or WHO stage 3 or 4[27]. In this study 
we defined late enrollment in care based on the WHO 2010 treatment guidelines, in order to 
describe progress toward meeting the goal of universal access to treatment. Specifically, we 
(1) examined changes between 2006 and 2011 in the proportion of HIV+ patients who 
enrolled late in HIV care and in the median CD4+ cell count at enrollment; and (2) 
identified individual-, program-, and contextual-level factors associated with late enrollment 
in care in 2011.
Methods
Study population
The study population included HIV-positive adults aged 15 to 85 years newly enrolling in 
HIV care between January 1, 2006 and December 31, 2011 at 138 HIV care facilities that 
provided continuous services during this time period in four sub-Saharan African countries: 
Kenya (64 facilities), Mozambique (29), Rwanda (24), and Tanzania (21). An additional 57 
facilities providing services in 2011 were included in the analysis of correlates of late 
enrollment in 2011 (N=195). All programs were receiving technical support from ICAP at 
Columbia University through funding from the United States President's Emergency Plan 
for AIDS Relief (PEPFAR). Provision of services at each facility was conducted according 
to national guidelines with all providing both pre-ART and ART services. These facilities 
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had implemented electronic databases to manage patient information routinely collected 
during each visit; when compared to all facilities supported by ICAP in those same countries 
during the study period, the facilities included in this analysis had higher patient volume, 
and were more likely to be located in urban areas and to be higher-level facilities (data not 
shown).
For this study, we included patients if CD4+ cell count and/or WHO clinical staging 
information were available up to three months after enrollment in HIV care, given that 
CD4+ counts are not always performed immediately at enrollment. Additionally, patients 
who were missing both CD4+ count and clinical stage were included if they initiated ART 
within one month of enrollment, as these patients enrolled late and likely were initiated on 
ART without documentation of CD4+ count and/or clinical stage.
Data sources
Patient information routinely collected during each clinic visit was documented by clinicians 
on national patient forms. This information was regularly entered into on-site electronic 
databases by data clerks. Data quality assessments were conducted at least annually at each 
facility using a standardized protocol. This entailed drawing a random sample of 
approximately 5-20% (depending on total patient volume) and assessing completeness and 
accuracy of key data elements. Remediation plans were developed for sites with poor data 
quality (<80% completeness and accuracy) and data quality was re-assessed after their 
implementation. Each quarter, data were de-identified at the site-level, encrypted, and 
imported into a common-format database. Use of these de-identified patient-level data for 
research purposes was approved by National Ethics Committees in each country, the 
Columbia University Medical Center Institutional Review Board, the United States Centers 
for Disease Control and Prevention, and the PEPFAR Office of the Global AIDS 
Coordinator (OGAC).
Data on facility characteristics were derived from structured assessments completed by 
ICAP staff in-country in August 2011. The assessment comprised 85 closed-ended questions 
about the types of HIV-related services provided at the facility and the characteristics of the 
HIV program (e.g., staffing configurations, availability of supportive services). 
Administration of this assessment was considered non-human subjects research because data 
referred to facilities, not individuals.
Contextual-level data were obtained from national Census and from country-specific, 
population-based surveys, namely the Demographic and Health Surveys and AIDS Indicator 
Surveys, using the most recently completed survey–2008 for Kenya, 2009 for Rwanda, 2011 
for Tanzania and Mozambique. For Kenya and Rwanda, 2011 estimates for contextual-level 
variables were imputed by extending the slope between the most recent available data and 
that from the previous time point.
Measures
The main study outcome, derived from the routinely collected patient data, was enrollment 
in HIV care with advanced HIV disease, or late enrollment in care. Late enrollment in care 
was defined as having CD4+ count ≤350 cells/μl and/or WHO clinical stage 3/4 documented 
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within three months of enrollment. In addition, those who were missing these parameters 
were considered to have enrolled in care late if they initiated ART within one month of 
enrollment in care.
Predictors were selected based on our conceptual framework, including factors that might 
influence late testing or delayed enrollment after diagnosis(22). Individual-level variables 
examined included age, sex, pregnancy status, marital status, and point of entry into care. 
The latter was categorized as voluntary counseling and testing [VCT] service, prevention of 
mother-to-child transmission [PMTCT] program, or provider-initiated testing and 
counseling [PITC] (including HIV testing among inpatients or outpatients in the general 
outpatient department, family planning clinic, TB clinic, or sexually transmitted infections 
[STI] clinic, depending on the country).
Facility-level variables examined included type of setting (urban, rural), type of facility 
(primary, secondary, tertiary, private), program size (i.e., number of patients active in HIV 
care, both in HIV care and on ART in the quarter prior to each individual's date of 
enrollment), number of days/week of facility operation, and availability of VCT and 
PMTCT on site.
Contextual measures were created for each of the 15 sub-national regions where one of the 
study facilities was located; they included HIV prevalence, HIV knowledge (mean score on 
five items assessing comprehensive HIV knowledge), testing coverage (percent of 
population tested and received results within the past 12 months), stigma (mean score on 
four items indicating acceptance of HIV+ people, reverse coded), education (percent of 
population having completed primary school), employment (percent of population 
employed), income distribution (percent of households in the first quintile of the national 
wealth index).
Statistical Analyses
We conducted two statistical analyses. The first assessed change over time in late enrollment 
in care and median CD4+ cell count at enrollment, and included the 138 facilities that 
provided services from 2006 to 2011. For late enrollment, statistical significance tests were 
performed using a Poisson regression model with generalized estimating equations (GEE) to 
account for clustering within facilities, treating calendar time as a continuous time measure. 
The models produced risk ratios for late enrollment per half year increase in calendar time. 
For median CD4+ count at enrollment we used the Kruskal Wallis test for comparisons over 
time. To assess the effect of missing outcome data on estimates of change over time, we 
multiply imputed outcomes for those missing both CD4+ count and WHO clinical stage at 
enrollment and compared the findings to those observed with complete data.
The second analysis examined correlates of late enrollment in care in 2011 and included the 
195 facilities providing services at that time. Relative risks of late enrollment in care were 
estimated using generalized linear models with a binomial distribution and a log link with 
GEE. Modeling was done in several steps. First, individual-level variables that were 
significantly associated with late enrollment in bivariate analyses were included in a 
multivariable model and retained if they were significant at p<0.05. Second, the same was 
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done for facility-level variables. Next, variables that were significant in each of these two 
multivariable models were combined into a two-level model and retained if they were 
significant. Fourth, as we did not have sufficient regions to assess the independent 
associations of contextual-level variables with late enrollment, each contextual-level 
variable was added to the two-level model and retained if statistically significant. Finally, 
non-significant correlates were dropped unless they altered other estimates by 10% or more. 
We conducted sensitivity analyses to determine if findings were altered if (1) the definition 
of late enrollment was based on the 2006 WHO treatment guidelines (CD4+≤200 cells/μL or 
WHO Stage 4 or; if missing CD4+ count, WHO Stage 3 or; if pregnant or active TB, 
CD4+≤350 cells/μL)[28]; (2) data for each country were removed; (3) the analysis was 
restricted to the 138 facilities used in the time trend analysis; and (4) patients defined as 
enrolling late only on the basis of having initiated ART within one month of enrollment 
were removed.
Results
Study population and missing data
In the 138 facilities that reported data from 2006 to 2011, 307,100 HIV-positive newly-
enrolled adult patients had data on CD4+ count and/or WHO stage. In 2006, 44,804 patients 
(83.5% of all newly enrolled adults) met these criteria; in 2011, the respective number was 
39,725 (91.4%) (Table 1). Considering the proportion missing both CD4+ count and WHO 
stage in 2006 and 2011, a consistent decrease was observed across all patient characteristics 
(Supplementary Table 1a). Additionally, among those missing CD4+ count but not WHO 
stage, the distribution of stage did not differ substantially between the two years 
(Supplementary Table 1b).
As shown in Table 1, across all study years, most patients were non-pregnant women 
(59.8%); aged 26 and 35 years (38.4%); and married or living with a partner (47.4%). 
Patients were most likely to have entered care via a PITC site (44.7%) or VCT (39.1%), with 
only 9.9% enrolled through PMTCT services. The largest proportion of patients was 
enrolled in Mozambique (54.8%). Between 2006 and 2011 there were statistically 
significant changes in the distribution of patients across all characteristics (p<.0001) except 
for those aged 25-36 years.
Change in late enrollment in HIV care and CD4+ cell count at enrollment, 2006-2011
Between 2006 and 2011 a significant decrease in late enrollment in HIV care was observed; 
the percent of patients that enrolled late declined from 69.9% in 2006 to 57.2% in 2011, 
corresponding to a 1.5% decline per half year change in calendar time (p<0.0001) (Table 1 
and Figure 1a). When we multiply imputed the outcome for those missing both CD4+ and 
stage, the estimate for change over time was only slightly attenuated; therefore, all reported 
results are those with complete data.
A statistically significant decline was observed among women, both non-pregnant (1.4%/
half-year, p<0.0001) and pregnant (3%/half-year, p<0.001), as well as among men (1%/half-
year, p<0.0001), and across all four countries (Kenya 1.9%/half-year, p<0.0001, 
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Mozambique 0.7%/half-year, p=0.05, Rwanda 2.6%/half-year, p<0.0001, Tanzania 3.1%/
half-year, p<0.0001) (Figure 1b). Additionally, the risk of late enrollment was significantly 
lower in 2011 compared with 2006 across subgroups defined by age, marital status, and 
enrollment point of entry (p<.0001 for all pairwise comparisons) (Table 1).
Among patients who had CD4+ count at enrollment (54.7% in 2006 and 60% in 2011), the 
median CD4+ count increased significantly from 242 cells/μL in 2006 to 292 cells/μL in 
2011 (ptrend<0.0001), or 50 cells/μL in 6 years (Figure 2a). A significant increase in median 
CD4+ count was noted over the study years among non-pregnant and pregnant women, and 
men (ptrend<0.0001) (Figure 2a), and in all countries (ptrend<0.0001) (Figure 2b). 
Considering the full distribution of CD4+ count at enrollment including those missing 
(Figure 3), the proportion with CD4+ ≥350 cells/μL increased from 19% to 24.8% of 
patients (with an increase from 10.8% to 14.5% among those with CD4+ ≥500 cells/μL), and 
the proportion with CD4+ <200 cells/μL decreased from 23.4% to 21.6% (overall χ2 p<.
0001).
Multi-level correlates of late enrollment in HIV care, 2011
In the 195 facilities that reported data in 2011, 46,201 newly-enrolled adult patients had 
sufficient information to define whether they enrolled late in care (91% of all newly-enrolled 
adults); of these, 55.6% enrolled late (Table 2). In unadjusted analyses, all patient-level 
variables examined were significantly associated with late enrollment. At the facility level, 
risk of late enrollment was lower in primary and private sites relative to tertiary sites, and it 
was higher in facilities with larger patient loads. At the contextual level, higher HIV 
prevalence, HIV stigma, and coverage of primary education were significantly associated 
with higher risk of late enrollment in care, whereas higher population testing coverage, HIV 
knowledge, and employment were associated with lower risk of late enrollment.
In multivariable analyses, relative to pregnant women, non-pregnant women had a 
significantly higher risk of late enrollment (ARR=1.52; 95%CI: 1.34, 1.72), as did men 
(ARR=1.74; 95% [CI: 1.54, 1.98). Other individual-level factors associated with higher risk 
of late enrollment were older age relative to age 15-25 years (ARR:26-45 years=1.28; 
95%CI:1.22, 1.34; ARR:46-55 years=1.35; 95%CI:1.28, 1.42); and, relative to being 
married or living with a partner, being widowed or divorced (ARR=1.14;95%CI:1.11, 1.71), 
never married (ARR=1.12; 95%CI:1.10, 1.15), or of unknown marital status (ARR=1.10; 
95%CI:1.06, 1.15). Compared with those enrolled through PMTCT services, risk of late 
enrollment in care was significantly higher for patients enrolled through VCT (ARR=1.34; 
95%CI:1.23, 1.47), PITC (ARR=1.54; 95%CI:1.41, 1.69), or an unknown point of entry 
(ARR=1.46; 95%CI:1.33, 1.60).
Of facility-level factors, patients enrolled in care at larger vs. smaller programs–measured 
by number of active patients–had a slightly higher risk of late enrollment (ARR=1.10; 
95%CI:1.00, 1.21 for programs with ≥700 vs. <300 active patients). With respect to 
contextual-level factors, risk for late enrollment in care was significantly lower in facilities 
located in regions with higher HIV testing coverage. Relative to regions where ≤20% of the 
population tested and received HIV results in the past year, in regions where ≥40% of the 
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population did so the ARR=0.76 (95%CI:0.58, 0.97). No other contextual-level variable 
retained significance in the final model.
In a sensitivity analysis using the WHO 2006 criteria for ART initiation to define late 
enrollment in care, non-pregnant vs. pregnant women did not have higher risk of late 
enrollment. The results of all other sensitivity analyses were consistent with the final model, 
although some estimates were slightly attenuated (data not shown).
Discussion
This study, using data from a large population of patients in diverse settings across four sub-
Saharan countries, is one of the few analyses, and the largest to date, of late enrollment in 
HIV care in this region. It demonstrated that enrollment in HIV care with advanced HIV 
disease declined over time concurrent with efforts to scale up HIV treatment in the same 
countries. (In 2006, 23% of those needing ART in sub-Saharan Africa were receiving it[29], 
and this percentage increased to 57% by 2011[30]). In our study, between 2006 and 2011, 
the prevalence of late enrollment in HIV care decreased from 69.9% to 57.2%, and the 
median CD4+ count at enrollment in care increased from 242 cells/μL to 292 cells/μL. A 
decline in late enrollment was observed across all categories of patients and in all four 
countries, strengthening the conclusion that these results reflect actual changes and are not 
merely a consequence of shifts in the characteristics of the patient populations enrolling in 
these programs. The possibility remains that some portion of the decline in late enrollment 
into care that we observed is due to a relative increase in the number of healthier individuals 
who had outcome data in the latter years of this study. However, based on analyses 
examining characteristics of patients missing outcome data in 2006 and 2011 and on 
reviewing multiply imputed outcome data, we believe this attenuation, if present, is small.
Despite these encouraging findings, our analysis also showed that in 2011, nearly a decade 
after HIV service scale-up began in sub-Saharan Africa, more than half of all individuals 
enrolled in care when they already were eligible for ART by 2010 WHO guidelines. Without 
a significant change in the observed rate of decrease in late enrollment in care—3% per year
—more than another decade will pass before fewer than one-quarter of patients will enroll 
late according to those guidelines. Given that the median time from HIV infection to 
reaching a CD4+ count <350 cells/μL is approximately four years[31], our study suggests 
that opportunities are missed to diagnose individuals earlier in disease, and underscores that 
greater efforts are needed to identify and link to care those with HIV infection prior to 
development of symptoms.
To further understand the factors associated with late enrollment in HIV care, we examined 
its correlates in 2011. More extensive HIV testing coverage in the areas surrounding the care 
facility was associated with a lower risk of late enrollment, even controlling for HIV 
prevalence, suggesting that expanded testing could lead to earlier enrollment in care. 
Community-based testing campaigns[7] and home-based counseling and testing[32] are 
important to pursue, although linkage to care after a positive HIV test may be a challenge 
with these approaches[32-34]. Research urgently needs to continue to explore these and 
other approaches to increase early diagnosis and prompt linkage to care.
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Of the facility characteristics examined, only larger program size, in terms of number of 
active patients, was associated with a small increase in risk of late enrollment. This could 
reflect greater travel distance from outlying areas to a large central clinic or scheduling 
constraints at large facilities. Individual characteristics were strong predictors of late 
enrollment, even accounting for facility and contextual factors. As observed in two other 
studies in sub-Saharan Africa[23, 35], being male, unmarried, and of older age were 
characteristics significantly associated with late enrollment in HIV care in our study. 
Women typically have more contact with the health care system[36], thus likely facilitating 
access to earlier HIV testing and engagement in HIV care, and this is especially true for 
pregnant women. Older people may be less likely to believe they are at risk for HIV, 
potentially resulting in delayed testing[23]. Being married or living with a partner may 
facilitate earlier enrollment, as having a partner known or suspected to be HIV-positive is a 
common motivation for HIV testing[37] and partner support may encourage prompt 
enrollment in HIV care[38].
A patient's point of entry into HIV care also was an important correlate of late enrollment. 
Individuals who were diagnosed through VCT or in a PITC setting were significantly more 
likely to enroll late, whereas individuals who entered care through PMTCT sites were less 
likely to do so, even accounting for sex and pregnancy status, probably reflecting the fact 
that all PMTCT clients are routinely offered HIV testing. Therefore, although costly, a 
policy of screening rather than testing based on symptoms or the presence of risk factors 
might reduce the proportion of individuals who enroll late in care.
This study had a number of strengths including the large number of patients from diverse 
sites across sub-Saharan Africa, use of data from routine clinical care, six years of data from 
the same facilities, which permitted analysis of trends over time unconfounded by changes 
in the number of facilities included each year, and the inclusion of facility and contextual 
correlates of late enrollment in addition to individual characteristics. A limitation was that 
CD4+ cell count data at enrollment were missing for 40-45% of individuals and, other than 
excluding those who transferred from another site, we were unable to exclude those who 
may have “newly-enrolled” more than once. Furthermore, we had limited power to detect 
associations with contextual-level factors with only 15 sub-national regions.
In conclusion, we observed a substantial decrease in the proportion of patients enrolled in 
HIV care at advanced stages of HIV disease between 2006 and 2011 in 138 facilities across 
four sub-Saharan African countries. Despite this progress, the decline in late enrollment was 
slow, and 57% of patients in 2011 enrolled in care at thresholds below WHO 2010 ART 
treatment guidelines. Although the expansion of testing, care, and treatment has resulted in 
significant improvements in outcomes for HIV-positive individuals, substantial efforts are 
needed to ensure that further gains are achieved. Encouragingly, we found that several of the 
correlates of late enrollment in 2011 reflect modifiable factors. That people entering care via 
PMTCT and those living in regions with higher HIV testing coverage have lower risk of late 
enrollment underscores the importance of continuing to scale up testing in order to identify 
individuals earlier in disease. Innovative approaches to increase testing uptake prior to 
symptom development may most rapidly reduce late enrollment in care.
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Figure 1a. Percent late enrollment by sex and pregnancy status among newly-enrolled patients in 
138 facilities in 4 sub-Saharan African countries, 2006-2011
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Figure 1b. Percent late enrollment by country among newly-enrolled patients in 138 facilities in 
4 sub-Saharan African countries, 2006-2011
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Figure 2a. Median CD4+ count at enrollment by sex and pregnancy status among newly-enrolled 
patients in 138 facilities in 4 sub-Saharan African countries, 2006-2011
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Figure 2b. Median CD4 count at enrollment by country among newly-enrolled patients in 138 
facilities in 4 sub-Saharan African countries, 2006-2011
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Figure 3. Distribution of CD4 count in 2006 and 2011 among newly-enrolled patients in 138 
facilities in 4 sub-Saharan countries
Chi-squared test p<0.0001
Total n=53,641 for 2006 and 43,466 for 2011.
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